Vol.170 æ¯å¹ŽæäŸãæ¥æ¬ã®ããæ²»çå»âWarm 30âïŒ2023幎çïŒçºè¡šïŒ
é ãã°ããªãããæ°å¹ŽãããŸããŠããã§ãšãããããŸãã
èœç»ã®éçœãæ¥èªæ©ãšæµ·ä¿æ©ã®è¡çªäºæ ãšãå¿èœã¡çããªã幎åãšãªããŸããã
被çœãããçããŸã«ã¯ãå¿ãããèŠèãç³ãäžããŸãã
ç§ã¯äŸå¹ŽéããèŒç§ã§å¹Žæ«å¹Žå§ãéãããŠããã®ã§ãããæ¬éã®éã¯ãå±±ã®æšã ãåã¿ããã«å·Šå³ã«æ¯ããã®ãçªè¶ãã«èŠãããããã¯ããºãããšèº«äœãçŽæãããããªæºãã§ããã
ã€ã·ã¥ã©ã³ã¡ã«ãã¬2024幎åã®çºåãšããããšã§ãä»å·ã¯ãæ¯å¹ŽæäŸã®æ¥æ¬ã®ããæ²»çå»âWarm 30âïŒ2023幎çïŒãçºè¡šããŸãã
æ¬å¹Žãå€ããã¬ãæèªãããããããé¡ãããããŸãã
ââââââââââââââââââââââââââââââ
ãèšäº1ã æ¯å¹ŽæäŸãæ¥æ¬ã®ããæ²»çå»âWarm 30âïŒ2023幎çïŒçºè¡šïŒ
âââââââââââââââââââââââââââââââââââ
ã€ã·ã¥ã©ã³æ¯å¹ŽæäŸã®ããæ¥æ¬ã®ããæ²»çå»âWarm30âã2023幎çãåºãŸããïŒ
ã»ä¹³ãããããhttps://www.ishuran.com/trophies/2023-warm30-breast
ã»è¡æ¶²ããããhttps://blood.ishuran.com/trophies/2023-warm30-blood
ã»å©Šäººç§ãããhttps://women.ishuran.com/trophies/2023-warm30-women
ã»èºãããããhttps://lung.ishuran.com/trophies/2023-warm30-lung
âWarm30âã¯ãã³ãã¥ãã±ãŒã·ã§ã³ã»ã¿ã€ãã®æç¥šããææ³ã®æçš¿ãããµã³ãã¥ãŒã¬ã¿ãŒã®æåœãããã€ã·ã¥ã©ã³ç¬èªã®èгç¹ã§ãã€ã³ãæç®ããã©ã³ãã³ã°äžäœ30åã®ãã³ãã¥ãã±ãŒã·ã§ã³ã®åå»ãã§ãã
2016幎ã®ä¹³ããããæ¯å¹ŽéèšããŠçºè¡šããŠããŸããããã®é ããå€ããããååãé£ãç¶ããããŠããâåžžé£âã®å çãããã£ãããäžæ¹ãä»å¹Žã¯âæ°é¡âã®å çãããªãå¢ããå°è±¡ã§ãã
7幎çµã£ãŠãå»åž«ã®äžçã§ãçå®ã«ãäžä»£äº€ä»£ããé²ãã§ããŠããæããããŸãã
æšå¹ŽãããWarm30ã«éžåºãããå çæ¹ã«ã¯ãã€ã·ã¥ã©ã³ç¹è£œåäžPOPãé²åããŠããããšããã£ãŠãããã®åãçµã¿ãç é¢ãå çæ¹ã«ããªãèªç¥ãããããã«ãªã£ãŠããŸããã
éèªãªã©ã®ãæ¥æ¬ã®ããã®åå»xx人ãçãªç¹éã ãšãããããæåå»åž«ããåºãŠããªãã®ã§ãããâWarm30âã¯ãæ¥çæŽã®é·ãç§ã§ãåãäžããªãå çãäœäººãåºãŠããã®ãé¢çœããšããã§ãã
æ¥ã ãæ£è ããã«å¯ãæ·»ããªãã蚺çã«å±ãŸããŠããå çæ¹ã«ãšã£ãŠãå°ãã§ãå±ã¿ã«ãªããããâå¿åºŠäžåç¡ãâã®ã©ã³ãã³ã°ãä»åŸãç¶ç¶ããŠåããŸãã
ââââââââââââââââââââââââââââââ
ããååãé¡ãã 飿²»æ§ä¹³ããæ£è ããããµããŒãããã€ã³ã¹ã¿ã¢ã«ãŠã³ãã®ãã©ããŒ
âââââââââââââââââââââââââââââââââââ
ããªãã«ãã¬ãã£ãä¹³ãããåçºãã€ãªã¹ã¯ä¹³ãããé²è¡ã»åçºä¹³ãããªã©ã®ã飿²»æ§ä¹³ãããã®æ£è ããããµããŒããããã¢ãããŒãããšãããããžã§ã¯ãããããŸãã
ãã®ã¢ãããŒããšã®ãªã¢ãã»ãµã€ãšã³ã·ãºæ ªåŒäŒç€Ÿãå ±å¬ãã圢ã§ãã€ã³ã¹ã¿ã°ã©ã äžã§é£æ²»æ§ä¹³ããã®åçºãã£ã³ããŒã³ãæ¡åïŒãããïŒã€ã³ã¹ã¿ãã£ã³ããŒã³ããå§ãŸããŸããã
ãã¡ãã®ã€ã³ã¹ã¿ã°ã©ã ã®ã¢ã«ãŠã³ãããã©ããŒããããšã§ã
â¢é£æ²»æ§ä¹³ããã®æ£è ããã®æ¥åžžç掻ã«ã€ããŠç¥ãããšãã§ãã
â¢é£æ²»æ§ä¹³ããæ£è ããã®ããžãã£ããªæçš¿ãã¿ãŠå æ°ããããã
ãšãã£ãããšãæåŸ ã§ãããšã®ããšã
ã€ã³ã¹ã¿ã°ã©ã ã䜿ãããŠããæ¹ããã²åœè©²ã¢ã«ãŠã³ãããã©ããŒããŠããã ããã°å¹žãã§ããïŒã¢ã«ãŠã³ãã®ãã©ããŒã ãã§ãã®ã§ãç¹ã«ãéããããããšã¯ãããŸããïŒ
ãªããæ¬å å®¹ã®æ²èŒã«ã€ããŸããŠãã®ãªã¢ãã»ãµã€ãšã³ã·ãºæ ªåŒäŒç€Ÿããåºåè²»ãããã ããŠããŸãã
ã€ã·ã¥ã©ã³ãå¥å šãªåœ¢ã§ç¶ç¶ã»çºå±ãããŠããããã«ãç§ãä¿¡é Œã§ãããšå€æãããµãŒãã¹ãã¡ã«ãã¬äžã§ã玹ä»ãããã®å¯ŸäŸ¡ãäœããã®åœ¢ã§é ããšããä»çµã¿ãå°å ¥ããŠãããä»åã¯ãã®äžç°ã§ãã
äžèšã®è¶£æšããçè§£ããã ããå€ãã®çããŸã«ãååé ããŸããã幞ãã§ãã
ââââââââââââââââââââââââââââââ
ãèšäº2ãå°æ¹Ÿã®èºããæ£è ã®ç ç©¶ããæå¯ããããéºäŒåããã«æ€æ»ã®æçŸ©ãšå®å
âââââââââââââââââââââââââââââââââââ
æšå¹Ž11æã®ã¡ã«ãã¬å ã§ããèºããã®äºäŸããèŠããŠãããéºäŒåããã«æ€æ»ã®é ããå®åãšã¯ããšããèšäºãæžããŸããã
ïŒïŒ
ä»åãããæœèšã§éºäŒåããã«æ€æ»ãçšããŠèª¿ã¹ããšããã
ã»ã³ã³ãããªã³èšºæïŒã·ã³ã°ã«ïŒã§ã¯é°æ§ãšå€å®ãããŠããéºäŒåå€ç°ããéºäŒåããã«æ€æ»ããããšéœæ§ãšå€æãããã±ãŒã¹ãç¡èŠã§ããªãæ¯çã§åºãŠãã
ã»æ²»çè¬ãååšããéºäŒåå€ç°ãèŠã€ããæ¯çã¯ãã³ã³ãããªã³èšºæïŒãã«ãïŒã§ã®çµæããéºäŒåããã«æ€æ»ã®çµæã®æ¹ãããé«ã
ãšããçµæã«ãªããŸããã
1æœèšã§ã®ããŒã¿ãªã®ã§ç¢ºå®çãªããšã¯èšããŸããããéºäŒåããã«æ€æ»ãããããšã§ãããé©åãªæ²»çã«ç¹ããããæ£è ãããäžå®çšåºŠååšããŠããããšããã®ã¯ãããªãéèŠãªç€ºåã§ãã
ïŒïŒ
éºäŒåããã«æ€æ»ã®å®åãšæçŸ©ãæŽã«èããäžã§ãè峿·±ãç ç©¶çµæãå°æ¹Ÿããå æ¥åºãŠããŸããã
ãâ "Comprehensive Genomic Analysis of Patients With NonâSmall-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwanâãè¡æ¶²ããŒã¹ã®ctDNAã¢ãã»ã€ãçšããéå°çްèèºçæ£è ã®å æ¬çã²ãã è§£æïŒå°æ¹Ÿã®åäžæœèšã®BFASTããŒã¿ããŒã¹ããã®ç¥èŠãïŒJournal of Clinical OncologyïŒ
ããããã§ããããctDNAããšã¯è¡äžãªã©ã«æµããŠããããã现èã®éºäŒåã¬ãã«ã®æ¬ çã§ãããã®æ å ±ãèªã¿è§£ãããšã§ãããã®ç¹æ§ïŒéºäŒåå€ç°ïŒãæ€ç¥ããŸãã
ãBFASTãã¯ãåœéçã«è¡ãããŠãããè¡æ¶²ãçšããctDNAã®ç ç©¶ã§ãä»åã®è«æã¯ãã®äžã§å°æ¹Ÿã®æ£è ããã®ããŒã¿ã®ã¿ãè§£æãããã®ã§ãã
269人ãè¡æ¶²ãçšããctDNAã®éºäŒåããã«æ€æ»ã宿œãããã®å 264人ã¯ããç å€ã®çµç¹æ€äœã®æ€æ»ã宿œããŠããŸãã
çµç¹æ€æ»ã¯ãEGFR, ALK, ROS1, BRAFã®4ã€ã®éºäŒåå€ç°ã調ã¹ãã³ã³ãããªã³èšºæïŒã·ã³ã°ã«ïŒã§è¡ãªããäžéšïŒ20人ïŒããªãã·ã§ã³ãšããŠçµç¹æ€äœãçšããéºäŒåããã«æ€æ»ãè¡ãªããŸããã
çµæãæ¬¡ã®ããšãããããŸããã
ã»ctDNAã®éºäŒåããã«æ€æ»ããã人ã®å ã76%ã«æ²»çè¬ãååšããéºäŒåå€ç°ãæ€åºããã
ã»äžæ¹ãçµç¹æ€äœã®æ€æ»ã§ã¯ã54%ã«æ²»çè¬ãååšããéºäŒåå€ç°ãæ€åºããã
ã»çµæãctDNAã®éºäŒåããã«æ€æ»ãè£å®çã«äœ¿çšããããšã§ãæ²»çè¬ãååšããéºäŒåå€ç°ã®æ€åºçã¯42ïŒ å¢å ãã
ã·ã³ã°ã«ã®ã³ã³ãããªã³èšºæã ãšãããããã®éºäŒåå€ç°ã調ã¹ãã«ã¯éçãããã®ã§ããã®çµæã¯åœç¶ã§ããã¯ãéºäŒåããã«æ€æ»ãåæã«è¡ãªãæ¹ããããé©åãªæ²»çã«çµã³ä»ãæããšèšããŸãã
æ©ãŸããã®ã¯ãããŒã¿ãããèŠããšãEGFR, ALK, ROS1, BRAFã«é¢ããŠã¯ãctDNAã®éºäŒåããã«æ€æ»ã§ããæ€åºãããªãã±ãŒã¹ãããäžæ¹ã§ãçµç¹æ€äœã§ã®ã³ã³ãããªã³èšºæã§ã®ã¿æ€åºãããã±ãŒã¹ãåããããããç¹ã§ãã
æ£è ããã®æ²»çæçžŸãäžããããšãèããããctDNAãããã¯çµç¹æ€äœã䜿ã£ãŠã®éºäŒåããã«æ€æ»ãåºæ¬è¡ãªã£ãŠãè£å®çã«ã³ã³ãããªã³èšºæãè¡ãªãããšããæ¹åæ§ãæ£ãããã§ãããä»åŸã®ç ç©¶ãšèšåºé©çšã®é²å±ã泚ç®ããŠãããããšæããŸãã
â»æ¬é å·çæç¹ïŒ2024幎1æ15æ¥ïŒã§ãçè ã¯äžéšã®éºäŒåããã«æ€æ»ã¡ãŒã«ãŒã®æ ªåŒãä¿æããŠããŸãã
âââââââââââââââââââââââââââââââââââ
ããã®è©±ã«ã€ããŠã©ãæããæããŠæ¬²ããããšãããããªãèŠæãã¡ãŒã«ãã¬ãžã³ã®å 容ã«ã€ããŠã®ã質åããæèŠãè§£çŽã®ãåžæãªã©ã«ã€ããŸããŠã¯ãè¿ä¿¡ã®åœ¢ã§ãæ°è»œã«ã¡ãŒã«ããŠãã ããã
é ä¿¡ããå 容ãšã¯ç¡é¢ä¿ã®è³ªåã§ãçµæ§ã§ããå¿ ããè¿äºããããŸãã ã¡ãŒã«ãã¬ãžã³ã®å 容ã®åŒçšã玹ä»ã転éããã©ãã©ããã£ãŠããã ããŠæ§ããŸããã
ããåãåããå ïŒ[email protected] ã
ã€ã·ã¥ã©ã³ã®æ°ãã詊ã¿ãšããŠããã以å€ã®çŸæ£ã§ãããç é¢ã»å»åž«æ€çŽ¢ãµã€ããç®èããããäœã£ãŠãããŸãã
ã€ã·ã¥ã©ã³ãšåãããå®éã«å蚺ããæ£è ããã®å£°ãã³ã³ãã³ããšãªã£ãŠããå å®ãããµã€ãã«æé·ããŠãããŸãã®ã§ãèªè ã®çããŸã«ããããŸããŠãããã²ãèªèº«ã®çµéšã«åºã¥ãããåç¥ã®ã¯ãªããã¯ãå çã«ã€ããŠãæç¥š/æçš¿ããŠé ãããšå¬ããã§ãã
âç®èããã: https://hifunavi.ishuran.com/
ç®èãã ç®èã®çç¶ã§æ©ãããªãã®ç é¢å»åž«æ€çŽ¢ãµã€ã
âSNSããã£ãŠããŸãããã²ãã©ããŒãããããé¡ãããããŸãã
ã»Facebookã¢ã«ãŠã³ãïŒhttps://www.facebook.com/ishuran.japan
ã»Twitterã¢ã«ãŠã³ãïŒhttps://twitter.com/ishuranjapan
ã»Instagramã¢ã«ãŠã³ãïŒhttps://www.instagram.com/ishuran_japan/
âã¡ã«ãã¬äŒå¡ïŒäŒå¡æ° â7â³äžäººïŒïŒ2023/12æç¹ïŒãžã®ç»é²ïŒç¡æïŒã¯ãã¡ãããâ
äŒå¡ç»é² ã€ã·ã¥ã©ã³ä¹³ãã(ä¹³ç) ç é¢ã»å»åž«ã¬ã€ã
ä¹³ãã(ä¹³ç)ã§ãŸãå¿ èŠãªã®ã¯ãç é¢ãå»åž«ãç確ã«ã¹ããŒãã£ã«éžã¶ããšãä¿¡é Œã§ããæ å ±æäŸãããªã·ãŒã«ãç§åŠçæ ¹æ ã«ããšã¥ãæ€æ»ãæ²»çããããªã£ãŠããä¹³ããã®ç é¢ãå»åž«ãäžèЧãªã¹ãã§ã玹ä»ããããªãã®åå»ããèŠã€ããŸãããã
ISHURAN.COM
ââââââââââââââââââââââââââââââ
ç§åŠçæ ¹æ ã«åºã¥ããªããäžè¬ã®æ¹ã«é¢çœãã»ãããæãå»çæ å ±ãäŒããŸã
ãåãåããã[email protected]
çºè¡ã»éå¶ãæ ªåŒäŒç€Ÿã¡ãã£ã«ã«ã»ã€ã³ãµã€ããéŽæšè±ä»
ââââââââââââââââââââââââââââââ












